NDC properties for NDC 9 0069-1309
NDC item 00069130901
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-01 |
| NDC Item | 00069130901 |
| packaging | 1 mL in 1 VIAL, SINGLE-DOSE |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
NDC item 00069130904
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-04 |
| NDC Item | 00069130904 |
| packaging | 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |
NDC item 00069130910
| NDC 9 | 0069-1309 |
|---|---|
| NDC 10 | 0069-1309-10 |
| NDC Item | 00069130910 |
| packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01) |
| BLA | BLA125545 |
| FDA SPL set id | 792529 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2018-06-18 |
| Marketing status | ACTIVE |